PCOS care platforms are shifting the conversation from fertility to lifelong metabolic health
Dr. Dereck Mush, MD, MBA
Limbo
Tracks biometrics to deliver automated, real-time coaching for metabolic weight management.
What they do
Limbo pairs continuous glucose monitoring and smart scales with a predictive artificial intelligence system. The platform delivers instant, automated feedback on how daily choices impact metabolism, helping individual consumers lose weight and improve body composition.
The record
- Vertical
- Metabolic Health
- Sub-segment
- Metabolic health wearables
- Product type
- Platform software
- Stage
- Seed
- Headquarters
- London, United Kingdom
- Region
- Europe
- Founded
- 2020
- Total funding
- $6M raised
Notable investors: Hoxton Ventures, Shauneen Bruder.
Also in Metabolic Health
Related on The Signal
Dr. Dereck Mush, MD, MBA
Inverting the GLP-1 Axis: Antagonism and the Unintended Metabolic Casualties of Bariatric Surgery
Dr. Dereck Mush, MD, MBA
The $1 Billion Bet on Pre-Symptomatic Medicine: Who Will Own the Longitudinal Baseline?
Dr. Dereck Mush, MD, MBA
Continuous glucose monitors are now a mainstream wellness product. The evidence base has not fully kept pace
Dr. Dereck Mush, MD, MBA